The Foundation Seed Grant program has been extremely successful in providing research support to basic and clinical scientists and investigators in the United States and overseas. The Seed Grant program funds research in the following areas: treatment/therapy, patient care, early diagnosis, detection, cancer biology, basic science, prevention/metabolism and research core facilities. The goals of the Seed Grant Program are:
- To provide start-up funding for basic scientists and clinicians who intend to test innovative ideas for improving diagnosis and to develop new treatment modalities for pancreatic cancer.
- To obtain preliminary data required for additional funding from other agencies for pancreatic cancer research.
- To impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy.
- To establish collaborations within the field for mutual projects that can be considered for further funding.
Collaborative Seed Grant
As the scientific goals of the Foundation progress and evolve, we created a new funding opportunity. Our Collaborative Seed Grant is designed to encourage joint projects with two principal investigators. The two investigators may be at the same institution but must be independent. The Hirshberg Foundation is committed to the belief that collaboration amongst the world’s leading researchers will lead us to a cure for this disease.
Individual & Collaborative Seed Grant Information
- Submission deadline: August 15, 2023
- Notification of award decision: October 15, 2023
- earliest award start date: November 15, 2023
- Duration of award: 1 year. No-cost extension (1 year) may be requested.
- Amount of award: $75,000 (single investigator award) and $100,000 (two-investigator collaborative award). No indirect costs are provided. Salary support for mentors cannot be requested.
Applications are invited from US and international academic institutions and research organizations. The funding opportunity is available to all academic researchers, including research-track and clinical-track faculty, staff scientists, and post-doctoral trainees. Applicants with no independent research programs need to enlist the support and participation of a senior mentor with a track record in pancreatic cancer research.
Award selection process
Applications will be reviewed and scored by a panel of experts including members of the Hirshberg Foundation Scientific Advisory Board and outside reviewers as needed. Applications will be ranked based on their scientific merit scores and the programmatic priorities of the Foundation. We expect to fund 6-8 proposals. Formal reviews or feedback will not be provided to the applicants.
Award recipients will be required to submit a final report within 3 months of the completion of the grant.
Travel support for conference presentations
Award recipients may apply for additional travel support (up to $1000) after they attended a US or international meeting where they presented their work directly related to the Hirshberg research award.
Application format and components
Use 11 pt Arial font, single spaced text, and at least 0.7″ margins. Compile all documents into a single pdf file, and upload on the submission website.
Include the following documents.
- Application cover page with the applicant’s and institution’s information and signatures.
- Title and abstract (300 words or less).
- Research plan (3 pages) should include background and significance, hypothesis, specific aims, and approach with preliminary results (optional). Figures are included in the 3-page limit.
- References cited (1 page).
- Vertebrate animals (if applicable, 1 page).
- Protection of human subjects (if applicable, 1 page).
- Investigator’s and mentor’s NIH biosketch (5 pages or less).
- Investigator’s and mentor’s other support page (1 page).
- Mentor’s support letter (1 page).
- Budget justification is not required.
Special requirements for collaborative applications
The primary investigator should submit the application. Add separate face pages for the primary and secondary investigators with appropriate signatures. Include justification for the collaborative arrangement (1 page), and designate planned distribution of award funds between the two investigators (e.g. 50%-50%).